Literature DB >> 8203687

Correlates of needle sharing among injection drug users.

W Mandell1, D Vlahov, C Latkin, M Oziemkowska, S Cohn.   

Abstract

OBJECTIVES: The sharing of contaminated injection equipment is the primary mode of human immunodeficiency virus (HIV) transmission for injection drug users. This study examined demographic factors, life events, and drug use practices that are potential risk factors for sharing injection equipment.
METHODS: Between February 1988 and March 1989, 2921 active injection drug users were interviewed and questioned about their backgrounds, life-styles, and patterns of injection drug use.
RESULTS: Of 2524 participants who reported injecting drugs within the 6 months prior to study enrollment, 70.4% reported recent needle sharing. A multivariate analysis found needle sharing to be more frequent among those with a history of arrest and lower socioeconomic status, even after accounting for other demographic and drug use variables. In addition, recent needle sharing was higher in male homosexual or bisexual men than in their heterosexual counterparts.
CONCLUSIONS: These data suggest that injection drug users have an economic motive to share needles and that the availability of free and legal needles may reduce levels of needle sharing.

Entities:  

Mesh:

Year:  1994        PMID: 8203687      PMCID: PMC1614968          DOI: 10.2105/ajph.84.6.920

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  15 in total

1.  Heterosexual transmission of human immunodeficiency virus among intravenous drug users.

Authors:  R J Battjes; R W Pickens; Z Amsel; L S Brown
Journal:  J Infect Dis       Date:  1990-11       Impact factor: 5.226

2.  Trends of HIV-1 risk reduction among initiates into intravenous drug use 1982-1987.

Authors:  D Vlahov; J C Anthony; D Celentano; L Solomon; N Chowdhury
Journal:  Am J Drug Alcohol Abuse       Date:  1991       Impact factor: 3.829

3.  The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants.

Authors:  D Vlahov; J C Anthony; A Munoz; J Margolick; K E Nelson; D D Celentano; L Solomon; B F Polk
Journal:  NIDA Res Monogr       Date:  1991

4.  HIV seroconversion and disinfection of injection equipment among intravenous drug users, Baltimore, Maryland.

Authors:  D Vlahov; A Muñoz; D D Celentano; S Cohn; J C Anthony; H Chilcoat; K E Nelson
Journal:  Epidemiology       Date:  1991-11       Impact factor: 4.822

5.  Determinants of needle sharing among intravenous drug users.

Authors:  S Magura; J I Grossman; D S Lipton; Q Siddiqi; J Shapiro; I Marion; K R Amann
Journal:  Am J Public Health       Date:  1989-04       Impact factor: 9.308

6.  AIDS health education for intravenous drug users.

Authors:  S R Friedman; D C Des Jarlais; J L Sotheran
Journal:  Health Educ Q       Date:  1986

7.  Knowledge about AIDS and high-risk behavior among intravenous drug users in New York City.

Authors:  P A Selwyn; C Feiner; C P Cox; C Lipshutz; R L Cohen
Journal:  AIDS       Date:  1987-12       Impact factor: 4.177

8.  Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco.

Authors:  R E Chaisson; A R Moss; R Onishi; D Osmond; J R Carlson
Journal:  Am J Public Health       Date:  1987-02       Impact factor: 9.308

9.  Risk factors for human immunodeficiency virus infection in intravenous drug users.

Authors:  E E Schoenbaum; D Hartel; P A Selwyn; R S Klein; K Davenny; M Rogers; C Feiner; G Friedland
Journal:  N Engl J Med       Date:  1989-09-28       Impact factor: 91.245

Review 10.  Recommendations for control and prevention of human immunodeficiency virus (HIV) infection in intravenous drug users.

Authors:  P W Brickner; R A Torres; M Barnes; R G Newman; D C Des Jarlais; D P Whalen; D E Rogers
Journal:  Ann Intern Med       Date:  1989-05-15       Impact factor: 25.391

View more
  16 in total

1.  Selective risk taking among needle exchange participants: implications for supplemental interventions.

Authors:  T W Valente; D Vlahov
Journal:  Am J Public Health       Date:  2001-03       Impact factor: 9.308

Review 2.  Updating the infection risk reduction hierarchy: preventing transition into injection.

Authors:  David Vlahov; Crystal M Fuller; Danielle C Ompad; Sandro Galea; Don C Des Jarlais
Journal:  J Urban Health       Date:  2004-03       Impact factor: 3.671

3.  Injection drug users' perspectives on placing HIV prevention and other clinical services in pharmacy settings.

Authors:  Alexandra Lutnick; Patricia Case; Alex H Kral
Journal:  J Urban Health       Date:  2012-04       Impact factor: 3.671

4.  Satellite exchange in the Baltimore Needle Exchange Program.

Authors:  T W Valente; R K Foreman; B Junge; D Vlahov
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

5.  Determinants of current HIV risk behaviour among injecting drug users in Warsaw, Poland.

Authors:  K Stark; J Sieroslawski; R Müller; D Wirth; C Godwod-Sikorska; U Bienzle
Journal:  Eur J Epidemiol       Date:  1996-06       Impact factor: 8.082

6.  Correlates of risky injection practices among past-year injection drug users among the US general population.

Authors:  Lauren R Ropelewski; Brent E Mancha; Alicia Hulbert; Abby E Rudolph; Silvia S Martins
Journal:  Drug Alcohol Depend       Date:  2011-01-11       Impact factor: 4.492

7.  Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada.

Authors:  Benedikt Fischer; Emma Haydon; Jürgen Rehm; Mel Krajden; Jens Reimer
Journal:  J Urban Health       Date:  2004-09       Impact factor: 3.671

8.  Cost-effectiveness of alternative strategies for provision of HIV preexposure prophylaxis for people who inject drugs.

Authors:  Rui Fu; Douglas K Owens; Margaret L Brandeau
Journal:  AIDS       Date:  2018-03-13       Impact factor: 4.177

9.  Identifying heterogeneity among injection drug users: a cluster analysis approach.

Authors:  Souradet Y Shaw; Lena Shah; Ann M Jolly; John L Wylie
Journal:  Am J Public Health       Date:  2008-06-12       Impact factor: 9.308

10.  Correlates of hepatitis C viral clustering among people who inject drugs in Baltimore.

Authors:  Jada Hackman; Oluwaseun Falade-Nwulia; Eshan U Patel; Shruti H Mehta; Gregory D Kirk; Jacquie Astemborski; Stuart C Ray; David L Thomas; Oliver Laeyendecker
Journal:  Infect Genet Evol       Date:  2019-10-24       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.